In conclusion, our findings indicate that miR-497 suppresses angiogenesis and metastasis of HCC cells in vitro and in vivo by inhibiting the expression of VEGF and AEG-1, and highlight the therapeutic potential of miR-497 in HCC. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.